Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNA
2926
DELISTED
Paragon 28, Inc.
FNA
| $965K | ﹤0.01% |
+54,529
| New | +$1.05M |
|
2927
Nature's Sunshine
NATR
$354M
| $962K | ﹤0.01% |
51,980
+22,070
| +74% | +$375K |
|
|
STXB
2928
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $961K | ﹤0.01% |
33,371
+584
| +2% | +$15.4K |
|
2929
Ezcorp Inc
EZPW
$1.83B
| $960K | ﹤0.01% |
130,162
+4,028
| +3% | +$30.6K |
|
2930
Cipher Digital
CIFR
$9.13B
| $955K | ﹤0.01% |
+206,107
| New | +$1.5M |
|
|
CTO
2931
CTO Realty Growth
CTO
$824M
| $955K | ﹤0.01% |
46,608
+759
| +2% | +$14.1K |
|
2932
Miller Industries
MLR
$573M
| $953K | ﹤0.01% |
28,526
| – | – |
|
2933
Geron
GERN
$828M
| $948K | ﹤0.01% |
777,001
+4,012
| +0.5% | +$5.75K |
|
2934
Civista Bancshares
CIVB
$604M
| $947K | ﹤0.01% |
38,772
+1,458
| +4% | +$35.9K |
|
2935
VistaGen Therapeutics
VTGN
$9.89M
| $947K | ﹤0.01% |
16,181
+11
| +0.1% | +$716 |
|
2936
Primis Financial Corp
FRST
$399M
| $946K | ﹤0.01% |
62,892
+5,659
| +10% | +$86K |
|
2937
Veru
VERU
$36M
| $943K | ﹤0.01% |
16,002
-66
| -0.4% | -$5.05K |
|
|
EAR
2938
DELISTED
Eargo, Inc. Common Stock
EAR
| $941K | ﹤0.01% |
9,223
+2,165
| +31% | +$282K |
|
2939
Crescent Energy
CRGY
$3.79B
| $939K | ﹤0.01% |
+74,037
| New | +$1.02M |
|
2940
Oramed Pharmaceuticals
ORMP
$167M
| $939K | ﹤0.01% |
65,707
+1,456
| +2% | +$30.4K |
|
2941
Teekay
TK
$1.01B
| $935K | ﹤0.01% |
297,536
+237
| +0.1% | +$818 |
|
2942
Capital City Bank Group
CCBG
$888M
| $934K | ﹤0.01% |
35,361
+1,606
| +5% | +$43.4K |
|
2943
Peoples Financial Services
PFIS
$704M
| $932K | ﹤0.01% |
17,683
| – | – |
|
2944
AXT Inc
AXTI
$3.95B
| $930K | ﹤0.01% |
105,560
+3,977
| +4% | +$33.6K |
|
2945
Altimmune
ALT
$552M
| $924K | ﹤0.01% |
100,820
+2,565
| +3% | +$27.3K |
|
|
AKYA
2946
DELISTED
Akoya BioSciences
AKYA
| $922K | ﹤0.01% |
60,158
+13,392
| +29% | +$175K |
|
2947
SIGA Technologies
SIGA
$235M
| $922K | ﹤0.01% |
122,529
| – | – |
|
2948
Verastem
VSTM
$510M
| $922K | ﹤0.01% |
37,450
| – | – |
|
2949
Cue Biopharma
CUE
$113M
| $917K | ﹤0.01% |
2,702
+94
| +4% | +$36.4K |
|
2950
Full Truck Alliance
YMM
$9.85B
| $913K | ﹤0.01% |
+109,007
| New | +$1.44M |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.